Trihexyphenidyl
| Clinical data | |
|---|---|
| Trade names | Artane, Parkin, Pacitane, Hexymer |
| AHFS/Drugs.com | Monograph |
| MedlinePlus | a682160 |
| License data | |
| Pregnancy category |
|
| Routes of administration | Oral |
| ATC code | |
| Legal status | |
| Legal status | |
| Pharmacokinetic data | |
| Elimination half-life | 3.3-4.1 hours |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| IUPHAR/BPS | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.005.105 |
| Chemical and physical data | |
| Formula | C20H31NO |
| Molar mass | 301.474 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Trihexyphenidyl (THP, benzhexol, trihex, marketed as Artane and others) is an antispasmodic drug used to treat stiffness, tremors, spasms, and poor muscle control. It is an agent of the antimuscarinic class and is often used in management of Parkinson's disease. It was approved by the FDA for the treatment of Parkinson's in the US in 1949.
Trihexyphenidyl is a therapeutic alternative on the World Health Organization's List of Essential Medicines.